Showing 1 - 4 results of 4 for search 'K Meijer', query time: 0.03s
Refine Results
-
1
-
2
-
3
Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury by R. J. Eck, J. J. C. M. van de Leur, R. Wiersema, E. G. M. Cox, W. Bult, A. J. Spanjersberg, I. C. C. van der Horst, M. V. Lukens, R. O. B. Gans, K. Meijer, F. Keus
Published 2022-10-01
Article -
4
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study) by Tine M.H.J. Goedhart, Laura H. Bukkems, Michiel Coppens, Karin J. Fijnvandraat, Saskia E.M. Schols, Roger E.G. Schutgens, Jeroen Eikenboom, Floor C.J.I. Heubel-Moenen, Paula F. Ypma, L. Nieuwenhuizen, K. Meijer, Frank W. G. Leebeek, Ron A.A. Mathôt, Marjon H. Cnossen
Published 2022-01-01
Article